Analysts showing optimistic trends for PVH Corp.(NYSE:PVH): Sierra Oncology, Inc.(NASDAQ:SRRA)

0
0

PVH Corp. (PVH) will report its next earnings on Dec 02 AMC. The company reported the earnings of $1.32/Share in the last quarter where the estimated EPS by analysts was $0.24/share. The difference between the expected and actual EPS was $1.08/share, which represents an Earnings surprise of 450%.

Many analysts are providing their Estimated Earnings analysis for PVH Corp. and for the current quarter 18 analysts have projected that the stock could give an Average Earnings estimate of $-0.34/share. These analysts have also projected a Low Estimate of $-0.97/share and a High Estimate of $0.19/share.

In case of Revenue Estimates, 16 analysts have provided their consensus Average Revenue Estimates for PVH Corp. as 2.12 Billion. According to these analysts, the Low Revenue Estimate for PVH Corp. is 2.08 Billion and the High Revenue Estimate is 2.18 Billion. The company had Year Ago Sales of 2.6 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for PVH to be -121.3%. They are projecting Next Quarter growth of 129.37%. For the next 5 years, PVH Corp. is expecting Growth of 431.06% per annum, whereas in the past 5 years the growth was -120.75% per annum.

Some buy side analysts are also providing their Analysis on PVH Corp., where 3 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.93 and Average Volume (3 months) is 1.28 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 14.8.

The company shows its Return on Assets (ROA) value of -5.7%. The Return on Equity (ROE) value stands at -14.6%. While it’s Return on Investment (ROI) value is 6.2%.

While looking at the Stock’s Performance, PVH Corp. currently shows a Weekly Performance of 12.45%, where Monthly Performance is 32.21%, Quarterly performance is 39.69%, 6 Months performance is 77.66% and yearly performance percentage is -7.6%. Year to Date performance value (YTD perf) value is -10.93%. The Stock currently has a Weekly Volatility of 5.08% and Monthly Volatility of 5.16%.

Sierra Oncology, Inc. (SRRA) will report its next earnings on 0. The company reported the earnings of $-1.39/Share in the last quarter where the estimated EPS by analysts was $-1.64/share. The difference between the expected and actual EPS was $0.25/share, which represents an Earnings surprise of 15.2%.

Many analysts are providing their Estimated Earnings analysis for Sierra Oncology, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-1.63/share. These analysts have also projected a Low Estimate of $-1.94/share and a High Estimate of $-1.36/share.

Some buy side analysts are also providing their Analysis on Sierra Oncology, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.59 and Average Volume (3 months) is 22.78 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -83.7%. The Return on Equity (ROE) value stands at -100.8%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Sierra Oncology, Inc. currently shows a Weekly Performance of 9.62%, where Monthly Performance is 6.74%, Quarterly performance is 31.01%, 6 Months performance is 15% and yearly performance percentage is -2.29%. Year to Date performance value (YTD perf) value is 9.81%. The Stock currently has a Weekly Volatility of 3.17% and Monthly Volatility of 4.48%.

SHARE